IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management I, LLC

Q3 2020 Holdings

Filed 2020-11-13 | 4 holdings | $355.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
10X Genomics, Inc.(TXG)CLASS A COMMON88025U109$342.9K2,750,00096.5%
Novavax, Inc.(NVAX)COM670002401$7.2K66,8102.0%
Epizyme, Inc.(EPZMEUR)COM29428V104$2.9K243,7590.8%
Acceleron Pharma Inc.(XLRN)COM00434H108$2.1K19,1000.6%